BaoLing FuJin Announces March 2026 Revenue of 150 Million JPY (+17.1% Year-over-Year)
BaoLing FuJin reported March 2026 revenue of 150 million JPY, a 17.1% increase year-over-year. This growth in the biotechnology and healthcare sector highlights the company's expanding market presence.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 17:28 (58 min after Collected)
Company Code: 1760
Company Name: BaoLing FuJin
Industry: Biotechnology and Healthcare
Data Month: 2026-03
Monthly Revenue: 149,829 thousand JPY (150 million JPY)
Year-over-Year Change: +17.1%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
Company Name: BaoLing FuJin
Industry: Biotechnology and Healthcare
Data Month: 2026-03
Monthly Revenue: 149,829 thousand JPY (150 million JPY)
Year-over-Year Change: +17.1%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
FAQ
What was BaoLing FuJin's revenue for March 2026?
BaoLing FuJin's monthly revenue for March 2026 was approximately 150 million JPY (149,829 thousand JPY).
How did the revenue change compared to the same month last year?
It increased by 17.1% compared to the same month last year.
What kind of business does BaoLing FuJin operate?
BaoLing FuJin operates in the biotechnology and healthcare industry, offering related products and services.